Related Experiment Videos
[Diagnostic image (9). Chronic mucocutaneous candidiasis].
Nederlands Tijdschrift Voor Geneeskunde
|December 5, 2000
Summary
This case study shows fluconazole effectively treated lifelong mucocutaneous lesions caused by Candida albicans in an 18-year-old man. The antifungal medication significantly improved the patient's persistent skin and mucous membrane symptoms.
Area of Science:
- Dermatology
- Mycology
- Infectious Diseases
Background:
- Mucocutaneous lesions in adolescents can present diagnostic challenges.
- Persistent Candida albicans infections require effective therapeutic strategies.
Observation:
- An 18-year-old male presented with lifelong mucocutaneous lesions.
- Candida albicans was consistently isolated from these lesions.
Findings:
- Fluconazole treatment led to a notable reduction in the patient's mucocutaneous lesions.
- Demonstrates the efficacy of fluconazole in managing chronic candidiasis.
Implications:
- Highlights fluconazole as a viable treatment option for recalcitrant mucocutaneous candidiasis.
- Suggests further investigation into long-term management of such cases.